PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
MEDNAX, Inc. (MD)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS58502B1061
CUSIP58502B106
SectorHealthcare
IndustryMedical Care Facilities

Highlights

Market Cap$759.60M
PEG Ratio0.88
Revenue (TTM)$1.99B
Gross Profit (TTM)$467.03M
EBITDA (TTM)$194.02M
Year Range$7.70 - $15.06
Target Price$9.07
Short %7.79%
Short Ratio6.22

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


MEDNAX, Inc.

Popular comparisons: MD vs. WSM

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in MEDNAX, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%200.00%400.00%600.00%800.00%December2024FebruaryMarchAprilMay
-57.85%
755.26%
MD (MEDNAX, Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

MEDNAX, Inc. had a return of -3.12% year-to-date (YTD) and -38.87% in the last 12 months. Over the past 10 years, MEDNAX, Inc. had an annualized return of -16.99%, while the S&P 500 had an annualized return of 10.41%, indicating that MEDNAX, Inc. did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date-3.12%6.17%
1 month-7.49%-2.72%
6 months-19.63%17.29%
1 year-38.87%23.80%
5 years (annualized)-21.07%11.47%
10 years (annualized)-16.99%10.41%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20240.65%-2.24%9.62%-11.57%
2023-9.83%-26.88%10.98%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of MD is 12, indicating that it is in the bottom 12% of the market in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of MD is 1212
MEDNAX, Inc.(MD)
The Sharpe Ratio Rank of MD is 66Sharpe Ratio Rank
The Sortino Ratio Rank of MD is 1010Sortino Ratio Rank
The Omega Ratio Rank of MD is 1010Omega Ratio Rank
The Calmar Ratio Rank of MD is 2525Calmar Ratio Rank
The Martin Ratio Rank of MD is 1111Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for MEDNAX, Inc. (MD) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


MD
Sharpe ratio
The chart of Sharpe ratio for MD, currently valued at -0.96, compared to the broader market-2.00-1.000.001.002.003.004.00-0.96
Sortino ratio
The chart of Sortino ratio for MD, currently valued at -1.28, compared to the broader market-4.00-2.000.002.004.006.00-1.28
Omega ratio
The chart of Omega ratio for MD, currently valued at 0.84, compared to the broader market0.501.001.500.84
Calmar ratio
The chart of Calmar ratio for MD, currently valued at -0.40, compared to the broader market0.002.004.006.00-0.40
Martin ratio
The chart of Martin ratio for MD, currently valued at -1.33, compared to the broader market-10.000.0010.0020.0030.00-1.33
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.97, compared to the broader market-2.00-1.000.001.002.003.004.001.97
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.84, compared to the broader market-4.00-2.000.002.004.006.002.84
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.34, compared to the broader market0.501.001.501.34
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.50, compared to the broader market0.002.004.006.001.50
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 7.61, compared to the broader market-10.000.0010.0020.0030.007.61

Sharpe Ratio

The current MEDNAX, Inc. Sharpe ratio is -0.96. This value is calculated based on the past 12 months of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of MEDNAX, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00December2024FebruaryMarchAprilMay
-0.96
1.74
MD (MEDNAX, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


MEDNAX, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%December2024FebruaryMarchAprilMay
-92.00%
-4.49%
MD (MEDNAX, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the MEDNAX, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the MEDNAX, Inc. was 92.99%, occurring on Mar 18, 2020. The portfolio has not yet recovered.

The current MEDNAX, Inc. drawdown is 92.00%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-92.99%Dec 10, 20131578Mar 18, 2020
-89.74%Feb 1, 1999335May 26, 2000966Apr 2, 20041301
-76.76%Apr 6, 2006663Nov 20, 20081231Oct 14, 20131894
-54.33%May 30, 1996221Apr 14, 1997453Jan 29, 1999674
-26.52%Sep 13, 200427Oct 19, 2004135May 3, 2005162

Volatility

Volatility Chart

The current MEDNAX, Inc. volatility is 8.67%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%December2024FebruaryMarchAprilMay
8.67%
3.91%
MD (MEDNAX, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of MEDNAX, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items